Brian McKelligon
2023
In 2023, Brian McKelligon earned a total compensation of $2.9M as Chief Executive Officer at Akoya Biosciences, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $307,125 |
|---|---|
| Option Awards | $1,080,613 |
| Salary | $542,500 |
| Stock Awards | $984,000 |
| Other | $5,361 |
| Total | $2,919,599 |
McKelligon received $1.1M in option awards, accounting for 37% of the total pay in 2023.
McKelligon also received $307.1K in non-equity incentive plan, $542.5K in salary, $984K in stock awards and $5.4K in other compensation.
Rankings
In 2023, Brian McKelligon's compensation ranked 323rd out of 2,978 executives tracked by ExecPay. In other words, McKelligon earned more than 89.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 323 out of 2,978 | 89th |
Division Manufacturing | 180 out of 1,637 | 89th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 20 out of 256 | 92nd |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 2 out of 53 | 96th |
Industry Laboratory Analytical Instruments | 2 out of 18 | 89th |
Source: SEC filing on April 23, 2024.
McKelligon's colleagues
We found two more compensation records of executives who worked with Brian McKelligon at Akoya Biosciences in 2023.